BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32296664)

  • 1. Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors.
    Gu L; Li YY; Gu L; Xie L; Liu HM
    Front Pediatr; 2020; 8():106. PubMed ID: 32296664
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD.
    Zhu T; Wu P; Tan Z; Jin Q; Chen Y; Li L; Chen Z; Tang Y; Li J; Fang Z
    Front Pharmacol; 2023; 14():1124746. PubMed ID: 36860300
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of high risk factors for patient death and its clinical characteristics on pregnancy associated with pulmonary arterial hypertension].
    Bao Z; Zhang J; Yang D; Xu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):495-500. PubMed ID: 25327730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
    Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 7. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.
    Roofthooft MT; Douwes JM; Vrijlandt EJ; Berger RM
    Am J Cardiol; 2013 Nov; 112(9):1505-9. PubMed ID: 23972345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and survival analysis of class I pulmonary arterial hypertension.
    Zheng L; Yang Y; Zhao W; Yang H; Zhan H; Zhao Y; Jiang R
    Am J Transl Res; 2023; 15(2):1476-1484. PubMed ID: 36915738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.
    Li W; Xiong CM; Gu Q; Wang XT; Cheng XL; Huang L; Yang T; Luo Q; Zhao ZH; Ni XH; Liu ZH; He JG
    Pulm Circ; 2018; 8(2):2045894018759918. PubMed ID: 29480092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.
    Luo J; Sun J; Xu L; Chen J; Chen Y; Chen W; Qiu H; Luo X; Chen S; Li J
    J Electrocardiol; 2023; 81():94-100. PubMed ID: 37657302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.
    Tomaszewski M; Małkowska P; Sierawska O; Hrynkiewicz R; Mroczek E; Darocha S; Hymos A; Błaszczak P; Grywalska E; Niedźwiedzka-Rystwej P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
    Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension.
    Zheng YG; Yang T; Xiong CM; He JG; Liu ZH; Gu Q; Zhao ZH; Ni XH
    Heart Lung Circ; 2015 Jun; 24(6):566-72. PubMed ID: 25573235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension].
    Zhang G; Shang X; Deng X; Zhou H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1001-5. PubMed ID: 25623345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential serum lipid distribution in IPAH and CHD-PAH patients.
    Chen J; Rathinasabapathy A; Luo J; Yang X; Luo P; Chen Y; Li Z; Li J
    Respir Med; 2022 Jan; 191():106711. PubMed ID: 34890866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease.
    Savale L; Manes A
    Eur Heart J Suppl; 2019 Dec; 21(Suppl K):K37-K45. PubMed ID: 31857799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].
    Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.